BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cavalcante-Silva LHA, Lima ÉA, Carvalho DCM, Rodrigues-Mascarenhas S. Ouabain reduces the expression of the adhesion molecule CD18 in neutrophils. Inflammopharmacology 2020;28:787-93. [PMID: 31087249 DOI: 10.1007/s10787-019-00602-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Carvalho DCM, da Silva PG, Dantas WM, da Silva SJR, da Silva CTA, Chaves EJF, de Araújo DAM, de Oliveira RN, Rodrigues-mascarenhas S, Pena LJ. Antiviral activity of ouabain against a Brazilian Zika virus strain. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-14243-5] [Reference Citation Analysis]
2 Galvão JGFM, Cavalcante-silva LHA, de Almeida Lima É, Carvalho DC, Alves AF, Mascarenhas SR. Ouabain modulates airway remodeling caused by Th2-high asthma in mice. International Immunopharmacology 2022;109:108808. [DOI: 10.1016/j.intimp.2022.108808] [Reference Citation Analysis]
3 Leite JA, Cavalcante-silva LHA, Ribeiro MR, de Morais Lima G, Scavone C, Rodrigues-mascarenhas S. Neuroinflammation and Neutrophils: Modulation by Ouabain. Front Pharmacol 2022;13:824907. [DOI: 10.3389/fphar.2022.824907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Cavalcante-Silva LHA, Carvalho DCM, de Almeida Lima É, Rodrigues-Mascarenhas S. Ouabain inhibits p38 activation in mice neutrophils. Inflammopharmacology 2021;29:1829-33. [PMID: 34792671 DOI: 10.1007/s10787-021-00882-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Souza E Souza KFC, Moraes BPT, Paixão ICNP, Burth P, Silva AR, Gonçalves-de-Albuquerque CF. Na+/K+-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection. Front Pharmacol 2021;12:624704. [PMID: 33935717 DOI: 10.3389/fphar.2021.624704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]